Long Term Follow Up for RAD001 Therapy of Angiomyolipomata in Patients With Tuberous Sclerosis (TSC) and Sporadic Lymphangioleiomyomatosis (LAM)

NCT00792766 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Tuberous Sclerosis
Angiolipoma

Interventions

DRUG: everolimus (RAD001)

Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

[object Object]